Nexalin Technology NXL
NASDAQ NXL
$5.73 -1.82 (-24.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026)

Updated

Nexalin Technology (NXL) posted Liabilities and Shareholders Equity of $3 million for Q2 2026, down 54.2% from $6.56 million a year earlier and down 18.7% from the prior quarter.

Analysis

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, Nexalin Technology's Liabilities and Shareholders Equity came in at $4.64 million, up 9.8% from FY2024.

  • Annual Liabilities and Shareholders Equity shows a four-year compound annual growth rate of 57.5% (FY2021 to FY2025).
  • In prior years, Nexalin Technology's Liabilities and Shareholders Equity was $4.22 million in FY2024 (+16.3%), $3.63 million in FY2023 (-51.1%), $7.43 million in FY2022 (+886.1%) and $753,698 in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 42.2%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2022, with growth of 886.1%; the weakest was Q2 2024, with a decline of 69.8%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $3.69 million (Q1 2026), $4.64 million (Q4 2025) and $5.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 241.25 Bn 220.40 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 167.33 Bn 138.41 Bn 7.27 Bn 109.22 Bn
3 Danaher 148.83 Bn 132.65 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 142.00 Bn 121.55 Bn 1.96 Bn 20.88 Bn
5 Medtronic 110.70 Bn 76.57 Bn 6.34 Bn 93.31 Bn
6 Stryker 104.72 Bn 90.84 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 62.66 Bn 57.67 Bn 3.85 Bn 45.22 Bn
8 Edwards Lifesciences 49.13 Bn 33.24 Bn 1.35 Bn 13.87 Bn
9 Becton Dickinson 48.51 Bn 45.66 Bn 2.32 Bn 50.73 Bn
10 Nexalin Technology 5.54 Mn -6.25 Mn 8,897.00 3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 3.69 Mn
Dec 31, 2025 4.64 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.56 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 4.22 Mn
Sep 30, 2024 5.26 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 4.43 Mn
Jun 30, 2023 5.18 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 8.35 Mn
Dec 31, 2021 753,698.00
API Access

Nexalin Technology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NXL&period=max&api_key=YOUR_API_KEY